Graft vs Host Disease
"Graft vs Host Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
Descriptor ID |
D006086
|
MeSH Number(s) |
C20.452
|
Concept/Terms |
Graft vs Host Disease- Graft vs Host Disease
- Graft-Versus-Host Disease
- Disease, Graft-Versus-Host
- Diseases, Graft-Versus-Host
- Graft Versus Host Disease
- Graft-Versus-Host Diseases
- Runt Disease
- Disease, Runt
- Graft-vs-Host Disease
- Disease, Graft-vs-Host
- Diseases, Graft-vs-Host
- Graft-vs-Host Diseases
- Homologous Wasting Disease
- Disease, Homologous Wasting
|
Below are MeSH descriptors whose meaning is more general than "Graft vs Host Disease".
Below are MeSH descriptors whose meaning is more specific than "Graft vs Host Disease".
This graph shows the total number of publications written about "Graft vs Host Disease" by people in this website by year, and whether "Graft vs Host Disease" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1984 | 0 | 1 | 1 | 1985 | 0 | 1 | 1 | 1987 | 0 | 1 | 1 | 1991 | 7 | 2 | 9 | 1992 | 3 | 3 | 6 | 1993 | 0 | 2 | 2 | 1994 | 1 | 3 | 4 | 1995 | 3 | 4 | 7 | 1996 | 2 | 7 | 9 | 1997 | 3 | 6 | 9 | 1998 | 0 | 1 | 1 | 1999 | 3 | 3 | 6 | 2000 | 4 | 6 | 10 | 2001 | 2 | 2 | 4 | 2002 | 2 | 3 | 5 | 2003 | 2 | 7 | 9 | 2004 | 2 | 5 | 7 | 2005 | 3 | 3 | 6 | 2006 | 4 | 4 | 8 | 2007 | 6 | 2 | 8 | 2008 | 4 | 2 | 6 | 2009 | 4 | 7 | 11 | 2010 | 5 | 4 | 9 | 2011 | 6 | 2 | 8 | 2012 | 5 | 1 | 6 | 2013 | 4 | 7 | 11 | 2014 | 2 | 2 | 4 | 2015 | 6 | 5 | 11 | 2016 | 1 | 8 | 9 | 2017 | 4 | 7 | 11 | 2018 | 0 | 4 | 4 | 2019 | 5 | 2 | 7 | 2020 | 9 | 1 | 10 | 2021 | 4 | 0 | 4 | 2022 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Graft vs Host Disease" by people in Profiles.
-
Chaekal OK, Gomez-Arteaga A, Chen Z, Soave R, Shore T, Mayer S, Phillips A, Hsu JM, Drelick A, Kodiyanplakkal RPL, Plate M, Satlin MJ, van Besien K. Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell Transplantation. Transplant Cell Ther. 2022 09; 28(9):618.e1-618.e10.
-
Nawas MT, Lee JO, Flynn J, Maloy M, Jakubowski AA, Papadopoulos EB, Cho C, Ponce DM, Sauter CS, Perales MA, Devlin S, Giralt SA, Castro-Malaspina HR, Tamari R. CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis. Bone Marrow Transplant. 2022 07; 57(7):1101-1107.
-
Gomez-Arteaga A, van Besien K. Allogeneic transplant graft source - conditioning - GVHD prophylaxis: don't mix and match! Leuk Lymphoma. 2022 01; 63(1):7-9.
-
Cooper JP, Perkins JD, Warner PR, Shingina A, Biggins SW, Abkowitz JL, Reyes JD. Acute Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Predicting This Rare Complication Using Machine Learning. Liver Transpl. 2022 03; 28(3):407-421.
-
Kaviany S, Kitko CL. The role of biomarkers in risk stratification, treatment and outcome in acute GVHD. Curr Opin Hematol. 2021 11 01; 28(6):401-407.
-
Sharma A, Huang S, Li Y, Brooke RJ, Ahmed I, Allewelt HB, Amrolia P, Bertaina A, Bhatt NS, Bierings MB, Bies J, Brisset C, Brondon JE, Dahlberg A, Dalle JH, Eissa H, Fahd M, Gassas A, Gloude NJ, Goebel WS, Goeckerman ES, Harris K, Ho R, Hudspeth MP, Huo JS, Jacobsohn D, Kasow KA, Katsanis E, Kaviany S, Keating AK, Kernan NA, Ktena YP, Lauhan CR, López-Hernandez G, Martin PL, Myers KC, Naik S, Olaya-Vargas A, Onishi T, Radhi M, Ramachandran S, Ramos K, Rangarajan HG, Roehrs PA, Sampson ME, Shaw PJ, Skiles JL, Somers K, Symons HJ, de Tersant M, Uber AN, Versluys B, Cheng C, Triplett BM. Outcomes of pediatric patients with therapy-related myeloid neoplasms. Bone Marrow Transplant. 2021 12; 56(12):2997-3007.
-
Yuen CA, Rezania K, Park DM, Reder AT. Asymptomatic brainstem lesions and pachymeningeal enhancement after anti-PD-1 therapy. Immunotherapy. 2021 01; 13(1):11-17.
-
Cardones AR, Hall RP, Sullivan KM, Hooten J, Lee SY, Liu B, Green CL, Chao NJ, Rowe Nichols K, Bañez LL, Shah A, Leung N, Palmeri ML. Quantifying Skin Stiffness in Graft-Versus-Host Disease, Morphea, and Systemic Sclerosis Using Acoustic Radiation Force Impulse Imaging and Shear Wave Elastography. J Invest Dermatol. 2021 04; 141(4):924-927.e2.
-
Nawas MT, Schetelig J, Damm F, Levine RL, Perales MA, Giralt SA, VanDenBrink MR, Arcila ME, Zehir A, Papaemmanuil E, Klussmeier A, Schmidt AH, Maiwald S, Bolton KL, Tamari R. The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation. Blood Rev. 2021 03; 46:100744.
-
Foss FM, Wang XV, Luger SM, Jegede O, Miller KB, Stadtmauer EA, Whiteside TL, Avigan DE, Gascoyne RD, Arber D, Wagner H, Strair RK, Hogan WJ, Sprague KA, Lazarus HM, Litzow MR, Tallman MS, Horning SJ. Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902. Transfusion. 2020 08; 60(8):1867-1872.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|